UPDATE: BMO Capital Downgrades bluebird bio (BLUE) to Market Perform

November 5, 2020 4:01 AM EST Send to a Friend
(Updated - November 5, 2020 5:03 AM EST)

(updating comment)BMO Capital analyst Matthew Luchini downgraded bluebird bio (NASDAQ: BLUE) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login